Before vaccines enter the market, they must go through several phases of clinical trials (figure below). Many vaccines may make it to phase I trials but only some will enter phase II, and even fewer to phase III. Clinical trials are essential as vaccines must be safe and effective. Even after a successful phase III clinical trial, post-licensure assessment is necessary to ensure the efficacy and safety of the vaccine is continually monitored.

Last updated July 2020